Cerevance Company

Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.

Investors

Industry: NeuroTech
Headquarters: Cambridge, Massachusetts, United States
Founded Date: 1/1/2016
Employees Number: 101-250
Funding Status: Early Stage Venture
Total Funding: 91500000
Last Funding Type: Series B
Visit Website
Register and Claim Ownership